Paxlovid is startlingly expensive. As with many drugs in the United States, its pricing deserves renewed scrutiny. Among a handful of approved anti-retrovirals, the drug is the go-to prescription medicine to treat mild-to-moderate COVID-19 in adults. It can reduce the likelihood of ending up in the hospital for people at elevated risk. For older people… Read More »
A special supplemental issue of Medical Care supports the growing recognition that patient economic outcomes matter in health care. Sponsored by the Assistant Secretary for Planning and Evaluation (ASPE) in the U.S. Department of Health and Human Services, the issue highlights studies that explore the relationship between economic outcomes, patient care, health outcomes and equity. Patient-centered… Read More »
Known as the fourth trimester of care, postpartum care has become unaffordable for many women. The costs of care are increasing, due to rising deductibles, increasing chronic diseases, and a lack of access to Medicaid. While postpartum care technically refers to the 12-week period after delivery, there is a movement to recognize that adequate postpartum… Read More »
In a previous post, we shared highlights from an event about fixing health care featuring Dr. Michael Fine, a family medicine physician, former public health official, and the author of Health Care Revolt. The faculty of the Department of Public Health at California State University Los Angeles led the event as part of a department-wide book read.… Read More »